DNA alkylation and interstrand cross-linking by treosulfan

British Journal of Cancer

Volumn 79, Issue 2, 1999, Pages 264-266

  Hartley, J A ^a   O'Hare, C C ^a   Baumgart, J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MEDAC GMBH   (Germany)

Author keywords

DNA alkylation; DNA cross linking; Treosulfan

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CHLORMETHINE DERIVATIVE; DNA; EPOXIDE; GUANINE; PLASMID DNA; PRODRUG; TREOSULFAN;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; DNA ALKYLATION; DNA CROSS LINKING; DRUG CYTOTOXICITY; DRUG DNA INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0032943945     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690043     Document Type: Article

References (15)

1. Breitbach GP, Villena C, Schwickerath J, Kunz T, Hurst U, Schmidt-Rhode P, Friedrich EJ, Artmeyer E, Schröder M, Eberl M, Franck J, Meinen K, Schiller S, Wernicke K, Sasse G, Schmid H and Bastert G (1994) Treosulfan bei fortgeschrittenem Ovarialcarcinom: eine Phase III-studie. Arch Gynecol Obstet 225 (suppl. 1): 80
2. Carmichael J, De Graff WG, Gazdar AF, Minna JD and Mitchell JB (1987) Evaluation of a tetrazolium based semi-automated colorimetric assay. I. Assessment of chemosensitivity testing. Cancer Res 47: 936-940
3. Feit PW (1961) Stereoisomere 1,4-di-O-methanesulfonyl-butan-2,3,4,4-tetrole. Tetrahedron Lett 20: 716-717
4. Feit PW (1964) 1,4-Bismethanesulfonates of the steroisomeric butane tetrads and related compounds. J Med Chem 7: 14-17
5. Feit PW, Rastrup-Andersen N and Matagne R (1970) Studies on epoxide formation from (2S,3S)-threitol 1,4-bismethanesulfonate. The preparation and biological activity of (2S,3S)-1,2-epoxy-3-4-butanediol 4-methanesulfonate. J Med Chem 13: 1173-1175
6. Fennelly JJ (1977) Treosulfan in the management of ovarian carcinoma. Br J Obstet Gynecol 84: 300-303
7. Hartley JA (1993) Selectivity in alkylating agent DNA interactions. In Molecular Aspects of Anticancer Drug DNA interactions. Neidle S and Waring MJ (eds.), pp. 1-31. Macmillan Press: Basingstoke
8. Hartley JA, Berardini MD and Souhami RL (1991) An agarose gel method for the determination of DNA interstrand crosslinking applicable to the measurement of the rate of total and 'second-arm' crosslink reactions. Anal Biochem 193: 131-134
9. Hilger RA, Harstrick A, Eberhardt W, Oberhoff C, Skorzec M, Baumgart J, Seebers S and Scheulen ME (1998) Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors. Cancer Chemother Pharmacol 42: 99-104
10. Kohn KW, Ewig RAG, Erickson LC and Zwelling LA (1981) Measurement of strand breaks and crosslinks by alkaline elution. In DNA Repair, vol 1B. Friedberg EC and Hanawalt PC (eds.), pp. 379-403. Dekker: New York
11. Mattes WB, Hartley JA and Kohn KW (1986) DNA sequence selectivity of guanine N7 alkylation by nitrogen mustards. Nucl Acid Res 14: 2971-2987
12. Ponti M, Forrow SM, Souhami RL, D'Incalci M and Hartley JA (1991a) Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucl Acids Res 19: 2929-2933
13. Ponti M, Souhami RL, Fox BW and Hartley JA (1991b) DNA interstrand crosslinking and sequence selectivity of dimethanesulphonates. Br J Cancer 63: 743-747
14. Scheulen ME, Hilger RA, Harstrick A, Oberhoff C, Freund M, Casper J, Skorzec M, Baumgart J and Seebers (1997) Clinical pharmacology of dose escalation of intravenous treosulfan with autologous stem cell support in patients with advanced solid tumors. Eur J Clin Pharmacol 52 (suppl.): A107
15. White FR (1962) L-Threitol dimethanesulfonate. Cancer Chemother Rep 24: 95-97